Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
33.71
-3.40 (-9.16%)
Apr 3, 2025, 11:35 AM EDT - Market open
PRAX Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for PRAX stock have an average target of 123.33, with a low estimate of 48 and a high estimate of 270. The average target predicts an increase of 265.86% from the current stock price of 33.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 3, 2025.
Analyst Ratings
The average analyst rating for PRAX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $175 → $85 | Strong Buy | Maintains | $175 → $85 | +152.15% | Mar 3, 2025 |
| Baird | Baird | Buy Maintains $117 → $73 | Buy | Maintains | $117 → $73 | +116.55% | Mar 3, 2025 |
| Needham | Needham | Strong Buy Maintains $150 → $85 | Strong Buy | Maintains | $150 → $85 | +152.15% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $105 | Strong Buy | Maintains | $120 → $105 | +211.48% | Mar 3, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $111 | Strong Buy | Initiates | $111 | +229.28% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
1.36M
from 8.55M
Decreased by -84.06%
Revenue Next Year
12.13M
from 1.36M
Increased by 789.73%
EPS This Year
-12.58
from -10.21
EPS Next Year
-12.14
from -12.58
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.0M | 70.4M | 186.2M | ||
| Avg | 1.4M | 12.1M | 74.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.6% | 5,068.4% | 1,435.7% | ||
| Avg | -84.1% | 789.7% | 514.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -10.49 | -8.88 | -6.98 | ||
| Avg | -12.58 | -12.14 | -10.92 | ||
| Low | -14.83 | -18.61 | -16.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.